Dishman Carbogen Amics (BOM:540701) Margin of Safety % (DCF Earnings Based): N/A (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540701 Dishman Carbogen Amics Ltd BOM:540701
65 GF Score
Price ₹169.90
GF Value ₹182.71
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dishman Carbogen Amics Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Dishman Carbogen Amics's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:540701 vs VRTX, REGN, MRNA: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Dishman Carbogen Amics's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dishman Carbogen Amics Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Margin of Safety % (DCF Earnings Based) falls into.


BOM:540701
65GF Score
Dishman Carbogen Amics Ltd BOM:540701
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dishman Carbogen Amics (BOM:540701) Overvalued in 2026?

Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued. The current stock price of ₹169.90 is trading 7% below its estimated GF Value™ of ₹182.71. GuruFocus considers Dishman Carbogen Amics to be Fairly Valued.

Key valuation signals for BOM:540701:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹182.71 vs. price of ₹169.90 (7% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the BOM:540701 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dishman Carbogen Amics Business Description

Other Exchanges DCAL:India
Address Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amcis Ltd is an Indian contract development and manufacturing organization (CDMO) serving pharmaceutical and biotechnology companies. It provides process development, scale-up, and commercial manufacturing of active pharmaceutical ingredients (APIs), intermediates, and advanced drug intermediates, along with niche products such as vitamin D3 analogues, cholesterol, and quaternary ammonium compounds used in disinfectants and personal care. The company operates through segments including CDMO, specialty chemicals, quats, and vitamins/cholesterol derivatives. Its customers include global pharmaceutical, generic, and life-science firms that outsource development and manufacturing. Operations and manufacturing sites are located in India and Europe, with sales across Europe, North America, India, China, and other international markets. Revenue is generated primarily through long-term CDMO contracts and product sales, with a significant share derived from European and other overseas markets.
65GF Score

Get the complete analysis for BOM:540701

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹169.90
Price
₹182.71
GF Value